Red‐Light Photocatalytic Activation of Pt(IV) Anticancer Prodrugs Using Methylene Blue

Abstract Catalysis‐based approaches offer versatile strategies for activating anticancer prodrugs, potentially allowing precise control over drug release and localization within tumor tissues while reducing systemic toxicity. In this study, we explore the role of the phenothiazine dye methylene blue ( MB + ) as a photocatalyst in conjunction with biologically relevant electron donors to facilitate the red‐light conversion of two Pt(IV) complexes, denoted as cis,cis,trans ‐[PtCl 2 (NH 3 ) 2 (O 2 CCH 2 CH 2 COOH) 2 ] ( 1 ) and trans ‐[Pt(O 2 CCH 2 CH 2 COOH) 2 1R,2R‐ (DACH)(ox)] ( 2 ), into cisplatin and oxaliplatin, respectively. Combining spectroscopic techniques (NMR, UV–vis, and flash photolysis) with computational methods, we reveal that the doubly reduced MB + (leucomethylene blue, LMB ) triggers the reductive elimination of axial ligands in the two Pt(IV) precursors, generating the corresponding Pt(II) anticancer drugs. In vitro experiments conducted on the human cervical cancer cell line CaSki, which harbors multiple copies of the integrated HPV‐16 genome, and on nontumoral cells (HaCat) demonstrate that coadministration with Pt(IV) prodrugs improves MB + ’s antiproliferative efficacy in cancer cells, particularly under red light exposure. This enhancement could be attributed to the catalytic production of Pt(II) species within the cellular environment.

Authors

Institutions

Publication Details

Journal
ChemCatChem
Published
2024-11-10
DOI
https://doi.org/10.1002/cctc.202401424
Citations
1
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
0.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Red‐Light Photocatalytic Activation of Pt(IV) Anticancer Prodrugs Using Methylene Blue

Marco De Andrea, Stefano Scoditti, German Eduardo Pieslinger, Emilia Sicilia et al.
1 citations
ChemCatChem
Advanced biosensing and bioanalysis techniques
0.23
article

Red‐Light Photocatalytic Activation of Pt(IV) Anticancer Prodrugs Using Methylene Blue

Marco De Andrea, Stefano Scoditti, German Eduardo Pieslinger, Emilia Sicilia, Valentina Dell’Oste, Ana C. Carrasco, Greta Bajetto, Luca Salassa, Virginia Martínez‐Martínez, Francesco Gambino
article en
1 citations

Abstract

Abstract Catalysis‐based approaches offer versatile strategies for activating anticancer prodrugs, potentially allowing precise control over drug release and localization within tumor tissues while reducing systemic toxicity. In this study, we explore the role of the phenothiazine dye methylene blue ( MB + ) as a photocatalyst in conjunction with biologically relevant electron donors to facilitate the red‐light conversion of two Pt(IV) complexes, denoted as cis,cis,trans ‐[PtCl 2 (NH 3 ) 2 (O 2 CCH 2 CH 2 COOH) 2 ] ( 1 ) and trans ‐[Pt(O 2 CCH 2 CH 2 COOH) 2 1R,2R‐ (DACH)(ox)] ( 2 ), into cisplatin and oxaliplatin, respectively. Combining spectroscopic techniques (NMR, UV–vis, and flash photolysis) with computational methods, we reveal that the doubly reduced MB + (leucomethylene blue, LMB ) triggers the reductive elimination of axial ligands in the two Pt(IV) precursors, generating the corresponding Pt(II) anticancer drugs. In vitro experiments conducted on the human cervical cancer cell line CaSki, which harbors multiple copies of the integrated HPV‐16 genome, and on nontumoral cells (HaCat) demonstrate that coadministration with Pt(IV) prodrugs improves MB + ’s antiproliferative efficacy in cancer cells, particularly under red light exposure. This enhancement could be attributed to the catalytic production of Pt(II) species within the cellular environment.

ChemCatChemVol. 17(3)
Ikerbasque (ES), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), Consejo Nacional de Investigaciones Científicas y Técnicas (AR), University of the Basque Country (ES), Universidad de Buenos Aires (AR), Instituto de Química y Fisicoquímica Biológicas (AR), Department of Public Health (US), University of Calabria (IT), Donostia International Physics Center (ES), University of Turin (IT)
Ministerio de Ciencia, Innovación y Universidades, European Commission, Consejo Nacional de Investigaciones Científicas y Técnicas, Eusko Jaurlaritza, Euskal Herriko Unibertsitatea, Università degli Studi di Torino, Università della Calabria, Agencia Estatal de Investigación
Openalex Percentile: Top 41%
Advanced biosensing and bioanalysis techniques
0.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.